Journey Medical Corporation
DERM
$5.31
$0.061.14%
Weiss Ratings | DERM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Very Weak | |||
Risk Index | Weak | |||
Risk Grade | D | |||
Reward Grade | E | |||
Rating Factors | DERM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | -- | |||
Growth Index | Weak | |||
Efficiency Index | Very Weak | |||
Solvency Index | Good | |||
Total Return Index | Weak | |||
Volatility Index | Weak | |||
Beta / Standard Deviation | DERM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 0.51 | |||
Price History | DERM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | 3.31% | |||
30-Day Total Return | 9.71% | |||
60-Day Total Return | 9.94% | |||
90-Day Total Return | -0.19% | |||
Year to Date Total Return | 32.75% | |||
1-Year Total Return | 41.98% | |||
2-Year Total Return | 255.61% | |||
3-Year Total Return | 35.11% | |||
5-Year Total Return | -- | |||
52-Week High % Change | -22.93% | |||
52-Week Low % Change | 86.32% | |||
Price | DERM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $6.89 | |||
52-Week Low Price | $2.85 | |||
52-Week Low Price (Date) | Mar 25, 2024 | |||
52-Week High Price (Date) | Oct 04, 2024 | |||
Valuation | DERM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 110.93M | |||
Enterprise Value | 109.53M | |||
Price/Earnings (TTM) | -- | |||
Earnings Per Share (TTM) | -0.94 | |||
Earnings Per Share Growth | 12.19% | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | 1.89 | |||
Price/Book (Q) | 10.07 | |||
Enterprise Value/Revenue (TTM) | 1.90 | |||
Price | $5.31 | |||
Enterprise Value/EBITDA (TTM) | -7.42 | |||
Enterprise Value/EBIT | -6.08 | |||
Market Cap Category | Micro Cap | |||
Dividends and Shares | DERM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 20.54M | |||
Dividend Yield | -- | |||
Div. Per Share (Most Recent) | -- | |||
Dividend Per Share (TTM) | -- | |||
Payout Ratio (TTM) | -- | |||
Dividend Per Share (Most Recent) | -- | |||
Company Info | DERM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 480 434 6670 | |||
Address | 9237 East Via de Ventura Boulevard Scottsdale, AZ 85258 | |||
Website | journeymedicalcorp.com | |||
Country | United States | |||
Year Founded | 2014 | |||
Profitability | DERM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | -31.18% | |||
Profit Margin | -31.73% | |||
Management Effectiveness | DERM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | -17.33% | |||
Return on Equity | -- | |||
Income Statement | DERM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | 57.77M | |||
Total Revenue (TTM) | 57.77M | |||
Revenue Per Share | $2.81 | |||
Gross Profit (TTM) | 33.11M | |||
EBITDA (TTM) | -14.76M | |||
EBIT (TTM) | -18.02M | |||
Net Income (TTM) | -18.34M | |||
Net Income Avl. to Common (TTM) | -18.34M | |||
Total Revenue Growth (Q YOY) | -57.64% | |||
Earnings Growth (Q YOY) | -114.24% | |||
EPS Diluted (TTM) | -0.94 | |||
EPS Diluted Growth (Q YOY) | -115.00% | |||
Balance Sheet | DERM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 22.46M | |||
Cash Per Share (Q) | $1.09 | |||
Total Current Assets (Q) | 46.16M | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | 10.93M | |||
Current Ratio (Q) | 1.385 | |||
Book Value Per Share (Q) | $0.53 | |||
Total Assets (Q) | 64.04M | |||
Total Current Liabilities (Q) | 33.33M | |||
Total Debt (Q) | 21.07M | |||
Total Liabilities (Q) | 53.12M | |||
Total Common Equity (Q) | 10.93M | |||
Cash Flow | DERM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | 0.00 | |||
Cash from Financing (TTM) | 25.58M | |||
Net Change in Cash (TTM) | -2.29M | |||
Levered Free Cash Flow (TTM) | -20.76M | |||
Cash from Operations (TTM) | -27.87M | |||